¿Es punica granatum peel extract seguro durante el embarazo?
No EU ban/restriction or harmonised CLP reproductive (H360/H361) classification found for Punica granatum peel extract (CAS 84961-57-9) and the Cosmetic Ingredient Review (CIR) evaluated Punica granatum extracts in a safety assessment for cosmetic use. Peer‑reviewed human/placental studies report neutral or protective effects of pomegranate polyphenols rather than teratogenicity. Together these sources do not provide evidence of reproductive hazard for topical cosmetic use. (See CIR safety review; ECHA substance page; placental study).
Pregnancy-safe products containing punica granatum peel extract








Related ingredients
Frequently asked questions
- ¿Es punica granatum peel extract seguro durante el embarazo?
- No EU ban/restriction or harmonised CLP reproductive (H360/H361) classification found for Punica granatum peel extract (CAS 84961-57-9) and the Cosmetic Ingredient Review (CIR) evaluated Punica granatum extracts in a safety assessment for cosmetic use. Peer‑reviewed human/placental studies report neutral or protective effects of pomegranate polyphenols rather than teratogenicity. Together these sources do not provide evidence of reproductive hazard for topical cosmetic use. (See CIR safety review; ECHA substance page; placental study).
- ¿Es punica granatum peel extract seguro durante la lactancia?
- No data showing breast‑milk mediated infant harm from topical use of pomegranate peel extract and no regulatory bans/restrictions. Lactation resources and clinical studies of maternal pomegranate ingestion show metabolite transfer to milk but not demonstrated toxicity from typical exposures; topical cosmetic use would give substantially lower systemic exposure. (See LactMed summary and CIR review).
- ¿Es punica granatum peel extract seguro para la piel del bebé?
- No evidence of developmental reproductive hazard specific to infants; mechanism data absent. Exposure score increased by +1 for baby skin because infant skin has higher permeability and surface‑area‑to‑weight, and cosmetic ingredients with measurable dermal absorption (polyphenols can be absorbed orally/topically) warrant a conservative higher exposure rating even when adult absorption is low. No infant‑specific adverse data were identified for topical use of pomegranate peel extract.
- ¿Cómo puntúa VeriMom a punica granatum peel extract?
- VeriMom puntúa punica granatum peel extract en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a punica granatum peel extract en el embarazo?
- Consulta nuestra lista de alternativas seguras a punica granatum peel extract según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.